CSIR-NEERI transfers Saline Gargle RT-PCR technology to the MSME ministry
This low-cost and highly reliable technology will help in increasing testing in rural and tribal areas
This low-cost and highly reliable technology will help in increasing testing in rural and tribal areas
India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers
The agreements between the parties involve a total fee of Rs. 8 lakh plus taxes for the grant of the licenses on a non-exclusive basis to SPL
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Speakers are: Ch. A. P. Rameswara Rao, National President, BDMAI; Dr. Paidi Yella Reddy, Founder, President & CEO, Sapala Organics; K. V. Rama Gopal, Site Manager & Executive Director, Clariant India; Dr. K. Nagaiah, Chief Scientist, CSIR - Indian Institute of Chemical Technology, Hyderabad; Dr. Satyanarayana Thirunahari, Senior General Manager - Process Safety & Engineering, Laurus Labs; and Yadavendra Shalgaonkar, Assistant General Manager - Tube Sales, Alleima India
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
Subscribe To Our Newsletter & Stay Updated